Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

ENDRA Life Sciences (NDRA) Return on Capital Employed (2017 - 2025)

ENDRA Life Sciences has reported Return on Capital Employed over the past 5 years, most recently at 91.62% for Q4 2021.

  • Quarterly Return on Capital Employed rose 9767.0% to 91.62% in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 91.62% through Dec 2021, up 9767.0% year-over-year, with the annual reading at 123.96% for FY2021, 4073.0% up from the prior year.
  • Return on Capital Employed was 91.62% for Q4 2021 at ENDRA Life Sciences, down from 72.65% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 126.45% in Q1 2017 and troughed at 627.11% in Q3 2019.
  • The 5-year median for Return on Capital Employed is 91.62% (2021), against an average of 199.43%.
  • Year-over-year, Return on Capital Employed plummeted -19705bps in 2018 and then surged 42342bps in 2021.
  • A 5-year view of Return on Capital Employed shows it stood at 77.69% in 2017, then crashed by -254bps to 274.74% in 2018, then dropped by -19bps to 326.31% in 2019, then soared by 42bps to 189.29% in 2020, then surged by 52bps to 91.62% in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Return on Capital Employed are 91.62% (Q4 2021), 72.65% (Q3 2021), and 68.68% (Q2 2021).